Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ROCK2 | O75116 | 1/20 | 0.42 |
| ▸ | ARHGDIA | P52565 | 1/20 | 0.42 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5833647 | 0.85 | ROCK2 (0.45) | ROCK2ARHGDIAROCK1MAPT | |
| SCHEMBL9678342 | 0.83 | SIGMAR1 (0.45) | ROCK2ARHGDIAROCK1MAPT | |
| SCHEMBL6180409 | 0.80 | KDM4E (0.44) | ROCK2ARHGDIAROCK1MAPT | |
| SCHEMBL5833283 | 0.80 | GBA1 (0.46) | ROCK2ARHGDIAROCK1MAPT | |
| SCHEMBL5833935 | 0.77 | ROCK2 (0.41) | ROCK2ARHGDIAROCK1MAPT | |
| SCHEMBL1976246 | 0.76 | ROCK2 (0.44) | ROCK2ARHGDIAROCK1MAPT | |
| SCHEMBL1976244 | 0.76 | ROCK2 (0.44) | ROCK2ARHGDIAROCK1MAPT | |
| SCHEMBL4966858 | 0.76 | ROCK2 (0.44) | ROCK2ARHGDIAROCK1MAPT | |
| SCHEMBL6545137 | 0.76 | SIGMAR1 (0.44) | ROCK2ARHGDIAROCK1MAPT | |
| Hydrochloric Acid SCHEMBL6707460 | 0.75 | SIGMAR1 (0.43) | ROCK2ARHGDIAROCK1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7008955-B2 | (2-azabicyclo[2.2.1]hept-7yl) methanol derivatives as nicotinic acetylcholine receptor agonists | MERCK PATENT GMBH (DE) | 2006-03-07 | — | — | US | disclosed |
| US-20040039045-A1 | (2-azabicyclo[2.2.1]hept-7yl) methanol derivatives as nicotinic acetylcholine receptor agonists | MERCK PATENT GMBH (DE) | 2004-02-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040039045-A1 | (2-azabicyclo[2.2.1]hept-7yl) methanol derivatives as nicotinic acetylcholine receptor agonists | CHRNA1, CHRNA10, CHRNB1 | ROCK2 2739/4885ARHGDIA 1117/4885ROCK1 1757/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.